Drive the future of liquid biopsy

For years now, our team is passionated in tools and services development for biologists. We are specialised in biomolecules detection (nucleic acids, proteins, mono and polysaccharides, amino acids, immunoglobins and oligonucleotides) in complex matrices. Our one and only goal is to facilitate research, diagnosis, as well as treatment efficiency prediction and follow-up.

Our solutions
meet your needs

Our solutions are created for your needs, offering you simplicity, ergonomics and time saving. Adelis aims to answer today and tomorrow challenges, particularly the growing global demand for high sensitivity analytical methods to measure DNA size and concentration in biological matrices. This trend is particularly true in the field of oncology and the study of cfDNA.


Online concentration


Size separation


Online purification


Online collection

How does it works

BIABooster hub is based on the use of μLAS technology (micro Laboratory for Analysis and Separation of DNA). It enables simultaneous concentration and separation instead of sequential steps with classical methods.

One technology, Unlimited possibilities

µLAS Technology is a new paradigm for DNA handling which usually requires a large number of operations involving multiple technologies.

Clinical studies

In oncology, the use of cfDNA as a biomarker allows to differentiate cancer patients from healthy people and to follow the efficiency of a drug therapy. With leading academic and health organisations, our clinical research programmes aim to develop cfDNA size and concentration profiling for treatment results prediction and cancer detection tests.


Microfluidic µLAS technology
April 8, 2024
Genetic testing based on the analysis of circulating cell-free DNA (cfDNA) in body fluids, especially blood plasma, is raising interest for the management and follow-up of many diseases, including cancer.

Press Release

Essor de la technologie d’analyse génétique µLAS (BIABooster)
March 25, 2024
Utilisée dans le cadre d’une étude clinique dirigée par les Hôpitaux Universitaires de Marseille…


Health donors cfDNA profiles
December 7, 2023
Circadian rhythm and circulating cell-free DNA release on healthy subjects. In the last decade, clinical studies have investigated the clinical relevance of circulating cell-free-DNA

Interested in our technology?